CUMBERLAND PHARMACEUTICALS INC Quarterly Goodwill in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Cumberland Pharmaceuticals Inc quarterly Goodwill history and growth rate from Q4 2017 to Q3 2024.
  • Cumberland Pharmaceuticals Inc Goodwill for the quarter ending September 30, 2024 was $914K, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $914K $0 0% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $914K $0 0% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $914K $0 0% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $914K $0 0% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $914K -$1.02M -52.7% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $914K -$1.02M -52.7% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $914K -$1.02M -52.7% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $914K +$32K +3.63% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $1.93M +$1.05M +119% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.93M +$1.05M +119% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $1.93M +$1.05M +119% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $882K $0 0% Dec 31, 2021 10-K 2023-03-13
Q3 2021 $882K $0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $882K $0 0% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $882K $0 0% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $882K $0 0% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $882K $0 0% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $882K $0 0% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $882K $0 0% Mar 31, 2020 10-Q 2020-05-22
Q4 2019 $882K +$98K +12.5% Dec 31, 2019 10-K 2021-03-12
Q3 2019 $882K Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $882K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $882K Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $784K +$784K Dec 31, 2018 8-K 2020-12-10
Q4 2017 $0 Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.